The Intraocular Lenses Market Is Anticipated To Reach US$ 5,076.1 Million In 2022 And Grow At A CAGR Of 7.2% During The Following Five Years (2022-2030)

Intraocular Lenses Market
 Intraocular Lenses Market 

The intraocular lens (IOL) is a cutting-edge solution for improving patients' vision without requiring them to wear glasses or contacts all the time. Monofocal lenses and premium IOLs are the two main categories of Intraocular Lenses Market. Lenses called monofocals are used to correct vision exclusively at a single distance. Premium IOLs, on the other hand, can correct both near and far vision. The three main categories of premium IOLs are toric, multifocal, and monofocal lenses.

The growth of the Global Intraocular Lenses Market is anticipated to be fueled by key market players' focus on the development of novel intraocular lenses during the forecast period. Over the forecast period, the market for intraocular lens systems is anticipated to rise at a faster rate due to the development of novel intraocular lenses by major industry participants. For instance, Ocumetics Technology Corp., a Canadian business that conducts research and develops ophthalmic products, announced the start of a clinical trial programme for Bionic Lens in October 2021. It replaces the need for corrective glasses with an inflatable intraocular lens that fits into the eye's lens compartment. The lens's process involves restoring the normal dynamics of the eye muscles to enable the eye to support improved focus from a distance up close and extremely close.

Over the forecast period, leading players are anticipated to increase their use of company development tactics such as mergers, acquisitions, and collaboration to grow the market. Key market players are using company development methods including collaboration, which is anticipated to fuel Intraocular Lenses Market expansion over the forecast period. For instance, in May 2019, the Italian ophthalmic company SIFI and the Indian pharmaceutical company Zydus Cadila collaborated to market intraocular lenses in India. The Indian Central Drugs Standards Control Organization (Directorate General of Health Services) and Ministry of Health & Family Welfare have given their approval to SIFI's intraocular lenses. As a result, the partnership will provide surgeons with cutting-edge technology to enhance patients' quality of life and vision.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030